Design and fabrication aspects of a plutonium-incineration experiment using inert matrices in a “Once-Through-Then-Out” mode

In the plutonium incineration experiment, named ‘Once-Through-Then-Out’ (OTTO), that is being prepared by JAERI, PSI and NRG, the use of highly stable inert matrices will be examined. The inert matrices MgAl₂O₄ spinel and ZrO₂ are insoluble in nitric acid and are considered as good storage media for final disposal. These inert matrices will be used in this experiment, which is representative for an OTTO scenario. A total of 7 Pu-containing targets were prepared for an irradiation in the High Flux Reactor in Petten. The objective of the irradiation is to reach a very high Pu-burnup. The main parameters to be studied are stability under irradiation, swelling, fission gas release and chemical interactions in the fuel. Four targets will be equipped with thermocouples for on-line monitoring of central temperature. Four of the targets contain MgAl₂O₄ as an inert matrix, 2 targets contain ZrO₂ and one target contains mixed-oxide (MOX) fuel for reference purposes. The fissile plutonium concentration is 0.32–0.44 g cm⁻³. Both particle-dispersed fuel and homogeneous dispersions were fabricated in order to test the effect of the size of the fissile inclusions. The design of the experiment and the fabrication of the samples are discussed.     

Superconductive properties of vanadium and their impurity dependence

We report on a comprehensive study of the magnetic properties of the super-conductor vanadium. Starting from a high-purity sample (RRR=1900), we use magnetization measurements to evaluate the primary superconductive parameters of vanadium and their impurity dependence up to 3.1. For the clean limit we findT _c0 =5.47 K and ₀ =0.78. From the impurity dependence of the transition temperature an rms gap anisotropy of 16% is obtained. Furthermore, for Ginzburg-Landau parameters 1.5 an attractive flux line interaction is found. The experiments on H_c2 anisotropy show results comparable to those for niobium, i.e., a slow decrease of the anisotropy coefficient a₄ with increasing impurity parameter and a much faster decrease of the 1=6 component. A detailed analysis of these results awaits further progress of theory.This work was supported in part by Fonds zur Förderung der Wissenschaftlichen Forschung, Wien, under contract No. 3973.     

Brainstem auditory evoked potentials and visually evoked potentials in young patients with IDDM

OBJECTIVE: To investigate whether young IDDM patients develop central nervous dysfunction and to establish a possible relationship with various disease parameters. RESEARCH DESIGN AND METHODS: Thirty-two patients, aged 13.5 +/- 2 years, with disease duration of 6 +/- 2.6 years and age of onset of 7.7 +/- 3.2 years (group 1), and 21 patients with short-term disease, age 9.7 +/- 3.5 years, duration of disease < 2 years and age of onset of 9.4 +/- 3.3 years (group 2) were compared with age- and sex-matched control subjects. Exclusion criteria were clinical signs of neuropathy, retinopathy, nephropathy, or hearing impairment. Neurophysiological studies included auditory and visually evoked potentials (EPs). RESULTS: Patients in group 1 revealed increased P100 latencies of visually EPs (103.4 +/- 4.5 vs. 96.8 +/- 3.7 ms) and interpeak latencies I-V of auditory EPs (4.16 +/- 0.10 vs. 3.99 +/- 0.09 ms) and had abnormal latencies (values outside 2.5 SD) in 37%. However, short-term patients (group 2) had results within normal limits compared with control subjects. In group 1, longer disease duration and younger age at onset correlated with an increase of P100 latency (P < 0.001) and IPL I-V (P < 0.001). Patients with a history of severe hypoglycemic episodes had increased latencies compared with patients without hypoglycemia (P < 0.05). Furthermore, metabolic control during the last 2 years was related to P100 latencies (P < 0.05). CONCLUSIONS: EPs noninvasively detect subclinical central nervous system involvement in children and adolescents with IDDM. Most important risk factors are duration of disease and frequency of severe hypoglycemia.     

Tree automata for code selection

We deal with the generation of code selectors in compiler backends. The fundamental concepts are systematically derived from the theory of regular tree grammars and finite tree automata. We use this general approach to construct algorithms that generalize and improve existing methods.Funded by the ESPRIT Project #5399 (COMPARE)Funded by DFG SFB #124 VLSI-Design and Parallelism     

Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter/defibrillator

The purpose of this prospective study was to evaluate, on an intention-to-treat basis, the efficacy of d,l-sotalol and metoprolol with regards to the recurrence of arrhythmic events after implantable cardioverter defibrillator (ICD) implantation. After ICD implantation, 70 patients were randomly assigned to treatment with either metoprolol (mean dosage 104+/-37 mg/day in 35 patients) or d,l-sotalol (mean dosage 242+/-109 mg/day in 35 patients). During follow up ventricular tachycardia (VT), fast VT, and ventricular fibrillation (VF) episodes were calculated. Metoprolol treatment led to a marked reduction in the recurrence of arrhythmic events. Actuarial rates for absence of VT recurrence at 1 and 2 years were significantly higher in the metoprolol group compared with the d,l-sotalol group (83% and 80% vs 57% and 51%, respectively, p=0.016). The actuarial rates for absence of fast VT or VF were 80% in the metoprolol group compared with 46% in the d,l-sotalol group (p=0.002). During a follow up of 26+/-16 months, there were 3 deaths in the metoprolol group compared with 6 deaths in the d,l-sotalol group. Actuarial rates of overall survival were not significantly different in the 2 groups (91% vs 83%, p=0.287). In this prospective, randomized, controlled study the recurrence rate of ventricular tachyarrhythmias in patients treated with metoprolol was lower than in patients treated by d,l-sotolol.     

Risk of thromboembolic events in patients with atrial flutter

Based on multiple studies, clear, guided anticoagulation therapy is recommended for patients with atrial fibrillation. The value of anticoagulation therapy in patients with atrial flutter, however, is less well established. Little is known about the incidence of thromboembolism in patients with atrial flutter. We evaluated the risk of thromboembolism in 191 consecutive unselected patients referred for treatment of atrial flutter. A history of embolic events was noted in 11 patients. Acute embolism (<48 hours) occurred in 4 patients (3 after direct current cardioversion, 1 after catheter ablation). During follow-up of 26+/-18 months, 9 patients experienced thromboembolic events. During the follow-up, the overall embolic event rate (including acute embolism and thromboembolic events during follow-up) was 7 % in this patient population. Risk indicators for an embolic event in an univariate analysis were organic heart disease (p = 0.037), depressed left ventricular function (p = 0.02), history of systemic hypertension (p = 0.004), and diabetes mellitus (p = 0.0038). Using multivariate analysis, a history of hypertension was the only independent predictor for elevated embolic risk in this patient population (odds ratio = 6.5; 95% confidence intervals 1.5 to 45). Thus, the thromboembolic risk is higher than previously recognized for patients with atrial flutter. Anticoagulation therapy may decrease this risk.     

Catheter ablation in cardiac arrhythmia. Interventional therapy of symptomatic and threatening arrhythmias of the heart

Catheter ablation is a curative intervention for the treatment of supraventricular, but also ventricular, tachycardias that has proved both safe and effective. In patients with supraventricular tachycardias in underlying WPW syndrome or nodal tachycardia and appreciable symptoms, catheter ablation can be considered the treatment of choice. But many patients with monomorphic ventricular extrasystole that is difficult to control medically experience considerable subjective impairment in their daily life. It is possible that in such patients, too, catheter ablation may, sometime in the future, be used to cure their condition. However, long-term results must first be awaited.